Researcher: David Sulzer
Research Overview:
David Sulzer's research primarily centers on understanding the pathophysiology of neurodegenerative diseases, particularly Parkinson's disease, through innovative approaches such as drug repurposing, neuroprotection strategies, and advanced neuroimaging techniques. He investigates the role of mitochondrial dysfunction, neuroinflammation, and protein aggregation (notably involving alpha-synuclein) in disease progression. Utilizing methods like single-cell RNA sequencing and MRI-based anatomical mapping, his work aims to elucidate the mechanisms behind neuronal degeneration and the immune response in the central nervous system. Sulzer also explores the relationships between genetic factors (such as variants in HLA-DRB1) and immune system responses, emphasizing the importance of adaptive immunity, including the roles of T cells and neuroantigens in Parkinsonâ€™s pathology. His research further extends to understanding the neuroprotective potential of various therapies, identifying biomarkers, and examining the interplay between neurotransmitter systems and synaptic plasticity. Overall, Sulzer's multidisciplinary approach contributes to the development of novel therapeutic targets for Parkinson's disease and other neurodegenerative disorders, supporting a deeper comprehension of underlying mechanisms and clinical implications.